Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : MicroDose Therapeutx, Inc., a wholly owned subsidiary of Teva Pharmaceuticals Industries, Ltd

Femme et Homme Max 99 ans
MicroDose Therapeutx, Inc., a wholly owned subsidiary of Teva Pharmaceuticals Industries, Ltd MAJ Il y a 4 ans

This is a trial that is studying a new inhaled medicine, MDT-637, that is being researched for the treatment of a viral infection of the lungs that typically affects the young and the elderly (Respiratory Syncytial Virus, RSV). Adult volunteers will be infected with RSV (the infection is typically mild in adults), half of these volunteers will be treated with MDT-637, and the other half will receive placebo which has no effect on RSV The primary efficacy objective and endpoint of the study is to evaluate the antiviral effect (as defined by reduction in AUC of viral load) of aerosolized MDT-637, in a manner which mimics the timing ...

Pays Aucun
Organes Aucun
Spécialités Aucune

unknown

Plus d'informations